The Big Quit? Regulatory Career Motivations in 2023

Dennis Partners conducted our third-annual survey on Regulatory Career Motivations during the week of February 20, 2023. Since the start of The Great Resignation in 2021, a record number of employees have left their positions for new ones. A recent LinkedIn survey estimates as many as 70% of employees are still considering changing jobs this[…]

Pay Transparency is Coming: What Employers Should Consider Doing

Pay transparency is coming to the biopharma industry. In fact, there’s already some form of law in place in California, Colorado, Connecticut, Maryland, and Washington with new transparency laws enacting in New York on November 1, 2022.  Job boards such as Indeed are seeing an increase in companies sharing salary ranges.  LinkedIn’s latest Workforce Confidence[…]

Hiring Top Candidates in Today’s Competitive Market

In today’s market, it’s incredibly challenging to find the desired Regulatory talent for growing bio/pharma organizations.  We’ve seen companies adjust levels, rapidly promote people, and lower their expectations.  It’s an arduous process but once you finally are ready to make an offer, it’s becoming increasingly difficult to get the acceptance.  The biggest challenge is that[…]

The Great Resignation Continues? Regulatory Career Motivations in 2022

Dennis Partners conducted a survey in June 2021 to determine if and how The Great Resignation was impacting Regulatory Affairs professionals and their motivations to stay in their current position or seek a new one (survey results here). In order to better understand how Regulatory professionals are feeling about the current job market in 2022,[…]

Regulatory Salary Expectations: What’s Going on?

Companies across the US are all too familiar with current hiring challenges:  too many open roles and not enough qualified candidates. Fueled by “the Great Resignation” and a pandemic-era shift in priorities, along with a surge of new biotech companies and record IPOs, Regulatory Affairs job openings are at an all-time high. We are seeing[…]

Regulatory Landscape Newsletter – July 2021

This is our July 2021 Regulatory Landscape newsletter with monthly insights on the evolving market for regulatory professionals.    In June we saw over 150 new Regulatory roles at smaller and mid-sized biotech and pharma companies. This doesn’t include Regulatory positions at Big Pharma companies, Medical Device or Diagnostics firms.  As usual, most of these were[…]

The Great Resignation: Regulatory Career Motivations in 2021

As the post-pandemic job market continues to boom, much of the conversation dominating 2021 is around what experts are calling, “The Great Resignation”. This phrase was coined by associate management professor Anthony Klotz of Texas A&M University during a recent Bloomberg Businessweek interview; “’When there’s uncertainty, people tend to stay put, so there are pent-up[…]